Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stalevo in Early Parkinson's Disease
NCT06236230Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Nov 2023
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of levodopa in Parkinson's disease (PD), sponsored by The Second Affiliated Hospital of Soochow University. Primary endpoint: Unified Parkinson's Disease Rating Scale Part III at 8 weeks. Started Nov 2023; status: recruiting.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT06236230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06236230.